Pfizer, Merck, Lilly execs urge tax code revamp in letter to Congress

FiercePharma ---- Pharma’s top U.S. execs haven’t been shy about expressing their desire for tax reform — and now, they’re taking those wishes directly to Congress. Tuesday, 16 CEOs of major American companies — including Pfizer’s Ian Read, Eli Lilly’s David Ricks, Merck’s Ken Frazier and Celgene’s Mark Alles — put forth a letter to congressional leaders recommending a “comprehensive pro-growth” overhaul to the U.S. tax code, which they called a “major impediment to economic growth.”The way they see it, lowering rates and enacting other changes proposed by Reps. Paul Ryan, R-Wis., and Kevin Brady, R-Texas, would “free up much-needed capital for companies to invest here in the U.S." and “help stop corporate inversions and acquisitions of U.S. companies.” To learn more about Pfizer, Merck, Lilly execs urge tax code revamp in letter to Congress click on the picture below to read the article.